trial · primary record
VTx-002
Amyotrophic Lateral Sclerosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2027-10-15 |
| Primary endpoint | The number of participants with treatment related adverse events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT07287397 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:39.074Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07287397
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.